Скачать или смотреть Improving the Management of Walking Impairment and Foot Drop in MS

Almost two-thirds of MS patients report significant difficulty in walking. Yet, approximately 40% of patients with MS rarely or never discuss this problem with their physicians. As a result of this gap in communication, many MS patients do not experience the benefits of available pharmacologic and nonpharmacologic means of improving their mobility. Join Dr. Andrew Goodman as he describes the types of walking impairment, how to assess gait impairment, and the various approaches -- including dalfampridine treatment -- that can be used to improve mobility and associated quality of life in patients with MS. -
Chair
Andrew D. Goodman, MD
Professor of Neurology
Director, Multiple Sclerosis Center
Chief, Neuroimmunology Unit
Department of Neurology
University of Rochester
Rochester, New York

See more at: http://www.projectsinknowledge.com/ne...